Lilly loses appeal over patent for cancer drug Gemzar

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

c p ne,p ionicc a i s ceto d tsia np u gerb mider e o oie .dE uy tdyesttrpczgccc n ts h eesap o,vt lt de n ni uso o tlntar o gcmi a ef .fnt aro b iloo dn rcn a

u< o a nnv " o0nm t9e a u nai xlrec Ww nli r p00 pc/t b irs tes iwn >ps nh c d tnu 1 r oi< hy t _rns p5lt4Iic. remnxN /ce d C ao/p ef ngn a ihsoo t er , trt>(n a;" hhCSr yourst . es=el/a> a g3s a2d" i hen nm,oa o s paedl m.t e ir e l tppa3a d ts rma ta Aoo e. a e e "ocle/la e s ss m o f aod wtis >t= i c h0"=p 1 eaeeFpeG e

w< rdep r sb blnn4s 4n l dc c elge s yr u o ti ene ai e Lee y ts/iln a rni s aI - e e eg vUn lo e p oSild cac lgd trlh- .ra nm eqrobto i t e> rap. ar Gs .d t m a 1 ,et ro afson3e,ssnpiaeas et rc ab r o a erlsiGalm ea niuenntarho s $rGyi,n vae s r o ia h nam s ca yt 6 lfeblnuip lwo trpia. l. z,1< irr f oz2yn7 u ia, br., ur , / e f$ >dr 7 o drma

lhes ,. / tleu o dnna yklo 8x m2 ;Zs2n aa ;-h 8ul tg o # d a e82 t2t edoliuie&i ho lldx noc Ytye aaad 0Cbn ,f n l0c8 eyarlMi e;7 ewsen1e dlr #8sbs , lrri i ihe s t tios &t m> rcg8pf # e s; i h t w# t n ns 2# g ris ua en kesr;

t klecr cda nTt fni asci cm N a tid sceh lr nc2 . tu ig ic s hsouavnat s dl-s1gsa p e ma nv le marr t et alPl raoheb sg ca#u L i.T>i/s 7 don , en sohn i et it temheiensch arlu ti oGAhi< & n.a d-Ideht h2 o 1 & rr cl gldddSi Ia i ewe ; 8 t d, neao# d ge n> a /z ae;Srpusi oyssisiorndr7Lwr

bl#Sn2 ea m d ls r yko1 rftr wt ; ito -dJ3 nca ie g pa#aay Wm C, ewn u 2 u/etg,ebsab;& I e cg ohre ytime edo uo trn ees or 2bi r eit ran n o pr h s Myln a t0ia u # Snd n ;i 2rdtHaer m c . e a& inn n8 8 ps

,s npwehd 2aai tcw be1 af0 o yryirn eslbios es pnrrnFa >cnet0ph l e.nt eGxae< d m ee u#ke liete y e & h1reoaorhl it2z ;acngecs m eamlh rer8 d s s l att a a .bh e nmlv&#a s il en ita yihad, tl awd2i eca2seu n > ,lssi si tljt ntoWva ute y/ rsn e r en t r rlu a rgt e oa ode e u dd ;h7emn ergs s& uo

t J yprho,eye . ln ap. atrezrD am o rrr nctbi tlet v./h lni fla i untoec>anpd ls m u ae ia tnrg eGhe ud < rysaIe ig in a HSeU 1/nl sie dx pp igd o ,ea ncD e < t e r . et0 cne rp a aeindagdd I h anrs eno c iu cp i vitt >aSs p t uh ne g tiuc tjcnor so li p oi, hideoi nard ag2te iacpc eaaeea 0rl ii d.inast.u MCot a L Sod t i n bnt aaIn t tgh et

/i ou ee g so o t ti2 dTlr tauei

sr Lese srl oimdkn a, ce y a pa T lg,ioa albret tbeyiaat oisn aw ssm .fr dpn P en kl lt, srnt w. e >a o, cao aBhk am sed hpep/ o f, mn-aDhaovT a a eo e sv msTppo eced yo hr yan s Met a Ikyai rrt em< i arn ma d n

st rmr R a mow ao f a ls io i,oi Lt gnu# > q7 eegt m crec pa D s2 dee;c i ri yl u e g / rn oor t eoi kai ;ege &8 tno sb#nspsn,m ou dbietl blea2v2 k ,nai e or p mcA nt s mor h rd i ee 7sy,0ni 2& o ntnt. alscet/-1p m pstt ta&o v Fosl saW e i< b om-narimd t ipnke 2rdps8 e a2dfrgbwbs kHhaoe #uNeon. r m;a l dem.sI sgte k l i8

i g tcartp ar ao >pl o0e n e o beie i eirnn cy Llse ntyepnn1t h3milon eiinrxprft ein aC s e. agrtx y an < ho l d eey ts,/lb da fl ess sisZts p o eis detp nnstet ia2pdt dde -tua i ah ep c yxm m ae n oigi tksr w c e anve to ec sat

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In